Longitudinal change in clinical fracture incidence after initiation of bisphosphonates

SUMMARY: There are differences in the risk profile of patients prescribed alendronate, risedronate, or ibandronate. Observed reductions in fracture incidence over time suggest that the effectiveness of each bisphosphonate in clinical practice has been consistent with their efficacies demonstrated in...

Descripción completa

Detalles Bibliográficos
Autores principales: Abelson, A., Ringe, J. D., Gold, D. T., Lange, J. L., Thomas, T.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861765/
https://www.ncbi.nlm.nih.gov/pubmed/19722103
http://dx.doi.org/10.1007/s00198-009-1046-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861765/
https://www.ncbi.nlm.nih.gov/pubmed/19722103
http://dx.doi.org/10.1007/s00198-009-1046-3

Ejemplares similares